Former Ranbaxy Laboratories Chairman Malvinder Singh has hit back at Daiichi Sankyo’s claim that crucial facts about the USFDA investigations were concealed at the time the company was sold by his family and blamed the Japanese …
Daiichi Sankyo, the Japanese owners of Ranbaxy Laboratories are considering taking legal action against former promoters of the Indian drug maker – Malvinder Singh and Shivinder Singh the Economic Times reported. The company …
Indian pharma has taken a big hit with the Ranbaxy episode raising questions about the efficacy and safety of the billion dollar industry. Indian generic drugs are quite popular in the US and other parts of the world but they may …
Unlike India, China is not assisting in the fight against counterfeit medicines even though the influx has been mainly from that country, Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) says. …
The Medical Council of India (MCI) has advised deans of all medical colleges to prescribe generic drugs, parliament was told on Tuesday. The MCI has issued circulars to deans of all medical colleges, directors of post graduate …
India vouched for the safety and efficacy of drugs manufactured by it and asked African countries not to mix patent issues with those of quality. ‘India is the largest supplier of generic medicines in the world. These drugs are …
The United States 2013-14 Budget might actually have more effect on the Indian generic pharmaceutical companies than PC’s budget. The proposal is to increase the budge of the US Food and Drug Administration (FDA) which will …
While Big Pharma and other US companies are fuming against Indian generic drugs and the pharma industry, former president Bill Clinton lauded Indian drug companies like Ranbaxy and Cipla for their huge contribution in the battle …
India's apex court is in the witness box facing not-so-subtle protests from the $56.67-billion Swiss drugs giant Novartis that is on the losing side of a far-reaching ruling this week on the crucial area of innovation, research …
It seems the state government has finally woken up to the possibility of subsidised healthcare. According to the recent Supreme Court ruling, the state government has decided to use Generic drugs for all medicine supplies to …
The landmark ruling of the Supreme Court, rejecting Swiss drug maker Novartis AG's attempt to patent its cancer drug, has been welcomed by health experts saying the dictum would ensure that patients get access to cheaper …
In a landmark judgement, the Indian Supreme court dismissed the patent plea for an anti-cancer drug called Glivec by Novartis AG. Anti-leukaemia drug Glivec is one of the blockbuster drugs for the Swiss company, mopping up global …
The South African government must follow the lead of its BRICS peers like India and China to ensure that life-saving medicines are affordable, said Doctors without Borders (or Medecins Sans Frontieres), an international …
Our government, in fact all Indian governments irrespective ideology age seem to suffer from a condition that can only be described as red-tape amnesia. Or maybe it’s a clever ruse to forget about things that could increase …
